Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway

被引:5
|
作者
Ma, Zelong [1 ]
Zhou, Faxiao [1 ]
Jin, Hua [1 ]
Wu, Xiaoming [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Genet Aging & Tumor, Chenggong Campus,727 South Jingming Rd, Kunming 650500, Peoples R China
关键词
CXCL12/CXCR4/ACKR3; axis; STAT3 signaling pathway; targeted therapy; JAK2; IL6; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE MAMMARY CARCINOGENESIS; HUMAN HEPATOCELLULAR-CARCINOMA; CDDO-METHYL ESTER; DOWN-REGULATION; GASTRIC-CANCER; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTORS; ADENOCARCINOMA CELLS; PROTEIN INHIBITOR;
D O I
10.3390/cells13121027
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The reciprocal modulation between the CXCL12/CXCR4/ACKR3 axis and the STAT3 signaling pathway plays a crucial role in the progression of various diseases and neoplasms. Activation of the CXCL12/CXCR4/ACKR3 axis triggers the STAT3 pathway through multiple mechanisms, while the STAT3 pathway also regulates the expression of CXCL12. This review offers a thorough and systematic analysis of the reciprocal regulatory mechanisms between the CXCL12/CXCR4/ACKR3 signaling axis and the STAT3 signaling pathway in the context of diseases, particularly tumors. It explores the potential clinical applications in tumor treatment, highlighting possible therapeutic targets and novel strategies for targeted tumor therapy.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells
    Neves, Maria
    Marolda, Viviana
    Mayor, Federico
    Penela, Petronila
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [2] Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
    Xu, Dongsheng
    Li, Rongshi
    Wu, Jianguo
    Jiang, Li
    Zhong, Haizhen A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (13) : 1441 - 1451
  • [3] Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain
    Luo, Xin
    Tai, Wai L.
    Sun, Liting
    Pan, Zhiqiang
    Xia, Zhengyuan
    Chung, Sookja K.
    Cheung, Chi Wai
    MOLECULAR PAIN, 2016, 12
  • [4] CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
    Teicher, Beverly A.
    Fricker, Simon P.
    CLINICAL CANCER RESEARCH, 2010, 16 (11) : 2927 - 2931
  • [5] Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
    Zhou, Weiqiang
    Guo, Shanchun
    Liu, Mingli
    Burow, Matthew E.
    Wang, Guangdi
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) : 3026 - 3041
  • [6] Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked
    Koch, Christian
    Engele, Jurgen
    MOLECULAR PHARMACOLOGY, 2020, 98 (05) : 577 - 585
  • [7] The Role of the CXCL12/CXCR4 Signaling Pathway in Regulating Cellular Migration
    Worden, Austin N.
    Pittard, Emma Grace
    Stern, Matt
    Uline, Mark J.
    Potts, Jay D.
    MICROSCOPY AND MICROANALYSIS, 2025, 31 (02)
  • [8] Systemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway
    Yang, L.
    Wang, M.
    Guo, Y. Y.
    Sun, T.
    Li, Y. J.
    Yang, Q.
    Zhang, K.
    Liu, S. B.
    Zhao, M. G.
    Wu, Y. M.
    BRAIN BEHAVIOR AND IMMUNITY, 2016, 56 : 352 - 362
  • [9] CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis
    Wu, Xue
    Qian, Lu
    Zhao, Huadong
    Lei, Wangrui
    Liu, Yanqing
    Xu, Xiaoling
    Li, Jiawen
    Yang, Zhi
    Wang, Du
    Zhang, Yuchen
    Zhang, Yan
    Tang, Ran
    Yang, Yang
    Tian, Ye
    AGEING RESEARCH REVIEWS, 2023, 83
  • [10] Osteotropism of neuroendocrine tumors: role of the CXCL12/CXCR4 pathway in promoting EMT in vitro
    Cives, Mauro
    Quaresmini, Davide
    Rizzo, Francesca Maria
    Felici, Claudia
    D'Oronzo, Stella
    Simone, Valeria
    Silvestris, Franco
    ONCOTARGET, 2017, 8 (14) : 22534 - 22549